Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
Andreas M Pleil,1 Feyza Darendeliler,2 Helmuth G Dörr,3 Katherine Hutchinson,4 Hartmut A Wollmann5 1Pfizer Inc., San Diego, CA, USA; 2Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, Capa, Istanbul, Turkey; 3Department of Pediatrics, University of Erlangen, Erlangen, Germany; 4Q...
Guardado en:
Autores principales: | Pleil AM, Darendeliler F, Dörr HG, Hutchinson K, Wollmann HA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e63a0ea8940446f5b99d577e65a38984 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Usability of devices for self-injection: results of a formative study on a new disposable pen injector
por: Lange J, et al.
Publicado: (2014) -
Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study
por: Rapaport R, et al.
Publicado: (2013) -
An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®
por: Estella M Davis, et al.
Publicado: (2010) -
Penetration Force And Cannula Sliding Profiles Of Different Pen Needles: The PICASSO Study [Erratum]
por: Leonardi L, et al.
Publicado: (2019) -
Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population
por: Lange J, et al.
Publicado: (2015)